Triple

T20301446
Position Surface form Disambiguated ID Type / Status
Subject Alexion Pharmaceuticals E505487 entity
Predicate notableProduct P1448 FINISHED
Object Strensiq
Strensiq is a prescription enzyme replacement therapy used to treat patients with perinatal-, infantile- and juvenile-onset hypophosphatasia, a rare genetic bone disorder.
 E1423952 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Strensiq | Statement: [Alexion Pharmaceuticals, notableProduct, Strensiq]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Strensiq
Context triple: [Alexion Pharmaceuticals, notableProduct, Strensiq]
  • A. Evrysdi
    Evrysdi is an oral prescription medication used to treat spinal muscular atrophy (SMA) by increasing production of the survival motor neuron (SMN) protein.
  • B. Rinvoq
    Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
  • C. Anpezan
    Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
  • D. Emgality
    Emgality is a prescription monoclonal antibody medication used for the prevention and treatment of migraine and cluster headaches.
  • E. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Strensiq
Triple: [Alexion Pharmaceuticals, notableProduct, Strensiq]
Generated description
Strensiq is a prescription enzyme replacement therapy used to treat patients with perinatal-, infantile- and juvenile-onset hypophosphatasia, a rare genetic bone disorder.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Strensiq
Target entity description: Strensiq is a prescription enzyme replacement therapy used to treat patients with perinatal-, infantile- and juvenile-onset hypophosphatasia, a rare genetic bone disorder.
  • A. Evrysdi
    Evrysdi is an oral prescription medication used to treat spinal muscular atrophy (SMA) by increasing production of the survival motor neuron (SMN) protein.
  • B. Rinvoq
    Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
  • C. Anpezan
    Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
  • D. Emgality
    Emgality is a prescription monoclonal antibody medication used for the prevention and treatment of migraine and cluster headaches.
  • E. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b4b8ab648190906e18538c250148 completed April 16, 2026, 10:06 a.m.
NER Named-entity recognition batch_69e6770c700c81909da247cef0d0f1eb completed April 20, 2026, 6:57 p.m.
NED1 Entity disambiguation (via context triple) batch_6a08611762e481909ee2f41434c86aa5 completed May 16, 2026, 12:20 p.m.
NEDg Description generation batch_6a0863506f4481909c106c49f6b71191 completed May 16, 2026, 12:30 p.m.
NED2 Entity disambiguation (via description) batch_6a0863f4bb788190b6ef1fe57279badb completed May 16, 2026, 12:32 p.m.
Created at: April 16, 2026, 11:17 a.m.